From intermediate AMD to geographic atrophy: Biomarkers, endpoints, and a roadmap for next-generation clinical trials

Progress in Retinal and Eye Research · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles